The equivalent of a thallium binding residue from an archeal homolog controls cation interactions in brain glutamate transporters

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14297-302. doi: 10.1073/pnas.0904625106. Epub 2009 Aug 11.

Abstract

Glutamate transporters maintain low synaptic concentrations of neurotransmitter by coupling uptake to flux of other ions. Their transport cycle consists of two separate translocation steps, namely cotransport of glutamic acid with three Na(+) followed by countertransport of K(+). Two Tl(+) binding sites, presumed to serve as sodium sites, were observed in the crystal structure of a related archeal homolog and the side chain of a conserved aspartate residue contributed to one of these sites. We have mutated the corresponding residue of the eukaryotic glutamate transporters GLT-1 and EAAC1 to asparagine, serine, and cysteine. Remarkably, these mutants exhibited significant sodium-dependent radioactive acidic amino acid uptake when expressed in HeLa cells. Reconstitution experiments revealed that net uptake by the mutants in K(+)-loaded liposomes was impaired. However, with Na(+) and unlabeled L-aspartate inside the liposomes, exchange levels were around 50-90% of those by wild-type. In further contrast to wild-type, where either substrate or K(+) stimulated the anion conductance by the transporter, substrate but not K(+) modulated the anion conductance of the mutants expressed in oocytes. Both with wild-type EAAC1 and EAAC1-D455N, not only sodium but also lithium could support radioactive acidic amino acid uptake. In contrast, with D455S and D455C, radioactive uptake was only observed in the presence of sodium. Thus the conserved aspartate is required for transporter-cation interactions in each of the two separate translocation steps and likely participates in an overlapping sodium and potassium binding site.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Archaeal Proteins / genetics
  • Archaeal Proteins / metabolism
  • Aspartic Acid / genetics
  • Aspartic Acid / metabolism
  • Aspartic Acid / pharmacology
  • Binding Sites
  • Brain / metabolism*
  • Cations / metabolism*
  • Excitatory Amino Acid Transporter 2 / genetics
  • Excitatory Amino Acid Transporter 2 / metabolism*
  • Excitatory Amino Acid Transporter 2 / physiology
  • Excitatory Amino Acid Transporter 3 / genetics
  • Excitatory Amino Acid Transporter 3 / metabolism
  • Excitatory Amino Acid Transporter 3 / physiology
  • Female
  • HeLa Cells
  • Humans
  • Ion Transport / drug effects
  • Liposomes
  • Lithium / metabolism
  • Lithium / pharmacology
  • Membrane Potentials / drug effects
  • Mutation
  • Oocytes / drug effects
  • Oocytes / metabolism
  • Oocytes / physiology
  • Potassium / metabolism
  • Potassium / pharmacology
  • Protein Binding
  • Rabbits
  • Rats
  • Sodium / metabolism
  • Sodium / pharmacology
  • Thallium / metabolism*
  • Xenopus laevis

Substances

  • Archaeal Proteins
  • Cations
  • Excitatory Amino Acid Transporter 2
  • Excitatory Amino Acid Transporter 3
  • Liposomes
  • Aspartic Acid
  • Lithium
  • Sodium
  • Thallium
  • Potassium